Compare Honeywell International Inc (HON) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs UnitedHealth Group Inc — how do they compare? Honeywell International Inc trades at $207.73 (market cap $65.48B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 5.1× Honeywell International Inc's market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold Honeywell International Inc for 91 Days and UnitedHealth Group Inc for 97 Days on average.
| HON | UNH | |
|---|---|---|
Market Cap | $65.48B | $332.96B |
Volume | 2,047,782 | 7,273,749 |
Sector | Industrials | Health |
52-Week High | $248.79 | $436.35 |
52-Week Low | $188.14 | $259.02 |
Typical Hold Time | 91 Days | 97 Days |
Enterprise Value | $90.27B | $374.82B |
Dividend Yield | 1.36% | 2.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Honeywell International (HON) trades at $206.6, down 0.73% with bearish technical signals despite strong fundamental metrics including a low P/E of 7.94 and robust ROE of 47.43%. The company recently beat Q2 2026 EPS estimates and secured a $300 million refinery project, positioning for growth post-spinoff of its aerospace and advanced materials divisions. Analyst consensus remains strongly bullish with a $259.25 price target.
HON presents a compelling value opportunity with attractive valuation multiples and consistent earnings outperformance, though near-term technical weakness and increasing debt-to-asset ratios warrant caution. The company's strategic focus on automation and recent contract wins support long-term growth prospects despite cyclical industrial sector risks.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
